Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions

Chest

Volumn 141, Issue 1, 2012, Pages 183-189

  Marchi, Evaldo ^a,b   Vargas, Francisco S ^a   Acencio, Milena M ^a   Sigrist, Rosa M S ^b   Biscaro, Marjourie D A ^b   Antonangelo, Leila ^a   Teixeira, Lisete R ^a   Light, Richard W ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Jundiaí Medical College   (Brazil)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULOTROPIN;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STUDENT T TEST;

EID: 84855458791     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-3181     Document Type: Article

References (18)

1. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3(1):75-80.
2. Rahman NM, Davies RJO. Effusion from infections: parapneumonic effusions and empyema. In: Light RW, Lee G. Textbook of Pleural Diseases. 2nd ed. London, England: Hodder Arnold. 2008:341-367.
3. Davies HE, Davies RJ, Davies CW; BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(suppl 2):ii41-ii53.
4. Porcel JM, Galindo C, Esquerda A, et al. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions. Respirology. 2008;13(1):58-62.
5. Porcel JM, Vives M, Esquerda A. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions. Chest. 2004;125(1):160-164. (Pubitemid 38114579)
6. Rahman NM, Mishra EK, Davies HE, Davies RJ, Lee YC. Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am J Respir Crit Care Med. 2008;178(5):483-490.
7. Bowling MR, Chatterjee A, Conforti J, Adair N, Haponik E, Chin R Jr. Perceptions vs. reality: measuring of pleural fluid pH in North Carolina. N C Med J. 2009;70(1):9-13.
8. Light RW, Girard WM, Jenkinson SG, George RB. The incidence and significance of parapneumonic effusions. Am J Med. 1980;69(4):507-512.
9. Xirouchaki N, Tzanakis N, Bouros D, et al. Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest. 2002;121(3):815-820. (Pubitemid 34251447)
10. San José ME, Valdes L, Gonzalez-Barcala FJ, et al. Diagnostic value of proinflammatory interleukins in parapneumonic effusions. Am J Clin Pathol. 2010;133(6):884-891.
11. Chung CL, Chen CH, Sheu JR, Chen YC, Chang SC. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest. 2005;128(2):690-697. (Pubitemid 41140497)
12. Geyer M, Müller-Ladner U. Actual status of antiinterleukin-1 therapies in rheumatic diseases. Curr Opin Rheumatol. 2010;22(3):246-251.
13. Bosani M, Ardizzone S, Porro GB. Biologic targeting in the treatment of inflammatory bowel diseases. Biologics.2009;3:77-97.
14. Marie C, Losser MR, Fitting C, Kermarrec N, Payen D, Cavaillon JM. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med. 1997;156(5):1515-1522. (Pubitemid 27505518)
15. Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990;343(6256):336-340. (Pubitemid 120028524)
16. Yanagawa H, Yano S, Haku T, Ohmoto Y, Sone S. Interleukin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease. Eur Respir J. 1996;9(6):1211-1216. (Pubitemid 26231737)
17. Porcel JM. Pleural fluid tests to identify complicated parapneumonic effusions. Curr Opin Pulm Med. 2010;16(4):357-361.
18. Porcel JM, Vives M, Cao G, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J.2009;34(6):1383-1389.